First Time Loading...
S

Santhera Pharmaceuticals Holding AG
SIX:SANN

Watchlist Manager
Santhera Pharmaceuticals Holding AG
SIX:SANN
Watchlist
Price: 9.37 CHF 1.19% Market Closed
Updated: May 3, 2024
SANN
/
Cash Flow Statement
/
Cash from Financing Activities

Santhera Pharmaceuticals Holding AG
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santhera Pharmaceuticals Holding AG
Cash from Financing Activities Peer Comparison

Comparables:
ADCT
CRSP
BSLN
IDIA
KURN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Santhera Pharmaceuticals Holding AG
SIX:SANN
Cash from Financing Activities
CHf14m
CAGR 3-Years
50%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Cash from Financing Activities
$73.9m
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Cash from Financing Activities
$62.7m
CAGR 3-Years
-60%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Cash from Financing Activities
-CHf57.3m
CAGR 3-Years
N/A
CAGR 5-Years
-57%
CAGR 10-Years
-20%
Idorsia Ltd
SIX:IDIA
Cash from Financing Activities
CHf162.3m
CAGR 3-Years
396%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Cash from Financing Activities
-CHf171k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Santhera Pharmaceuticals Holding AG's Cash from Financing Activities?
Cash from Financing Activities
14m CHF

Based on the financial report for Dec 31, 2022, Santhera Pharmaceuticals Holding AG's Cash from Financing Activities amounts to 14m CHF.

What is Santhera Pharmaceuticals Holding AG's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-25%

Over the last year, the Cash from Financing Activities growth was -70%. The average annual Cash from Financing Activities growth rates for Santhera Pharmaceuticals Holding AG have been 50% over the past three years , -25% over the past five years .

ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.